Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,458
  • Shares Outstanding, K 25,688
  • Annual Sales, $ 31,640 K
  • Annual Income, $ -940 K
  • 60-Month Beta 1.17
  • Price/Sales 2.66
  • Price/Cash Flow 1,016.96
  • Price/Book 5.39
Trade ETON with:

Options Overview Details

View History
  • Implied Volatility 239.03% ( +50.93%)
  • Historical Volatility 65.60%
  • IV Percentile 98%
  • IV Rank 76.14%
  • IV High 307.17% on 04/05/24
  • IV Low 21.66% on 07/14/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 846
  • Open Int (30-Day) 935

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.03 +2.97%
on 04/17/24
4.10 -23.90%
on 04/02/24
-0.76 (-19.59%)
since 03/25/24
3-Month
3.03 +2.97%
on 04/17/24
4.75 -34.32%
on 02/06/24
-1.32 (-29.73%)
since 01/25/24
52-Week
2.42 +28.93%
on 07/31/23
5.81 -46.30%
on 09/15/23
-0.39 (-11.11%)
since 04/25/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 3.12 (-2.80%)
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...

AZYO : 1.4900 (+2.05%)
SIEN : 0.1740 (-18.69%)
BIOL : 0.1480 (+2.78%)
BTCY : 1.3000 (-6.47%)
ETON : 3.12 (-2.80%)
SWKH : 17.10 (+0.53%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 3.12 (-2.80%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eton Pharmaceuticals, Inc. - ETON

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Eton Pharmaceuticals, Inc. ("Eton" or the "Company") (NASDAQ: ETON). Such...

ETON : 3.12 (-2.80%)
Cytek Biosciences, Inc. (CTKB) Reports Break-Even Earnings for Q1

Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of -100% and 19.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CTKB : 5.63 (-0.53%)
ETON : 3.12 (-2.80%)
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 300% and 6.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

ETON : 3.12 (-2.80%)
USAQ : 0.0900 (-3.23%)
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Lags Revenue Estimates

Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of -56.94% and 85.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

VRDN : 12.70 (-2.53%)
ETON : 3.12 (-2.80%)
Patterson Cos. (PDCO) Surpasses Q3 Earnings Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 3.33% and 1.15%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

PDCO : 25.80 (-1.45%)
ETON : 3.12 (-2.80%)
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -196.88% and 7.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

EBS : 1.95 (-10.55%)
ETON : 3.12 (-2.80%)
Alkermes (ALKS) Beats Q4 Earnings and Revenue Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of 180% and 6.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ALKS : 24.44 (-0.85%)
ETON : 3.12 (-2.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

3rd Resistance Point 3.38
2nd Resistance Point 3.33
1st Resistance Point 3.22
Last Price 3.12
1st Support Level 3.06
2nd Support Level 3.01
3rd Support Level 2.90

See More

52-Week High 5.81
Fibonacci 61.8% 4.52
Fibonacci 50% 4.11
Fibonacci 38.2% 3.71
Last Price 3.12
52-Week Low 2.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar